WhiteOak Capital Pharma and Healthcare Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return Index
NAV: ₹16.57-0.77%
08 Jul 2026
Rolling Returns Analysis
Rolling annualized returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth across 1Y, 3Y and 5Y windows — average, best, worst returns and percentage of positive return periods.
| Metric | 1 Yr Rolling Returns | 3 Yr Rolling Returns | 5 Yr Rolling Returns | 7 Yr Rolling Returns |
|---|---|---|---|---|
| Analysis period | 12 Feb, 2025 - 08 Jul, 2026 | - | - | - |
| Average returns | 17.59% | - | - | - |
| Standard deviation | 9.47% | - | - | - |
| Best returns | 38.13% 1 year ending on 24 Mar, 2025 | - | - | - |
| Worst returns | 0.13% 1 year ending on 12 Jan, 2026 | - | - | - |
| Period with positive return | 100.00% | - | - | - |
| Period with return > 5% | 90.12% | - | - | - |
| Period with return > 10% | 75.58% | - | - | - |
| Period with return > 15% | 55.81% | - | - | - |
| Beat % Category | 100.00% | - | - | - |
| Beat % Benchmark | 82.56% | - | - | - |
Trailing Returns
Point-to-point returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth vs category average for YTD, 1M, 6M, 1Y, 3Y, 5Y and 10Y periods — with category rank and total funds count.
0%
10%
20%
30%
40%
16.7%
13.0%
12.3%
YTD
5.3%
4.7%
5.4%
1 M
15.3%
12.0%
11.2%
6 M
18.5%
12.5%
15.5%
1 Y
23.5%
45.3%
3 Y
14.7%
13.1%
5 Y
15.0%
9.0%
10 Y
Fund
Equity: Sectoral-Pharma
BSE Healthcare Total Return Index
| Name | YTD | 1 M | 6 M | 1 Y | 3 Y | 5 Y | 10 Y | Since Inception |
|---|---|---|---|---|---|---|---|---|
| Fund | 16.66% | 5.27% | 15.34% | 18.54% | - | - | - | 23.20% |
| Equity: Sectoral-Pharma | 13.03% | 4.72% | 11.99% | 12.51% | 23.52% | 14.72% | 15.05% | - |
| BSE Healthcare Total Return Index | 12.35% | 5.37% | 11.18% | 15.51% | 45.28% | 13.11% | 8.96% | - |
| Rank in category | 3 | 4 | 4 | 3 | - | - | - | - |
| Funds in category | 21 | 22 | 21 | 20 | 9 | 7 | 3 | - |
Period Returns
Calendar-year, quarterly and monthly return history of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth. Toggle between bar chart and table view to analyse periodic performance trends.
Historical Performance
Track NAV movement and cumulative returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth across 1M, 6M, 1Y, 3Y, 5Y and since-inception periods. Compare SIP and lumpsum growth over time.
Compare performance with respect toAdd benchmark
Add benchmark
Frequently Asked Questions
What are the 1-year returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
The 1-year trailing return for WhiteOak Capital Pharma and Healthcare Fund Direct-Growth is shown in the Trailing Returns section. It is compared against the Equity: Sectoral-Pharma category average and benchmark for context.
What are the 3-year returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
The 3-year CAGR for WhiteOak Capital Pharma and Healthcare Fund Direct-Growth is in the Trailing Returns section, with benchmark and category comparisons.
What are the 5-year returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
The 5-year CAGR for WhiteOak Capital Pharma and Healthcare Fund Direct-Growth is in the Trailing Returns section. 5-year CAGR is a standard metric for medium-term performance consistency.
What are the returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth since inception?
WhiteOak Capital Pharma and Healthcare Fund Direct-Growth has delivered a CAGR of 23.20% since its launch. The fund's maximum historical drawdown has been -0.15%, indicating its worst peak-to-trough decline during this period. Since-inception returns capture performance across multiple market cycles and are most useful for evaluating long-term wealth creation.
How has WhiteOak Capital Pharma and Healthcare Fund Direct-Growth performed vs its category over the long term?
Performance vs category average across 1Y, 3Y, 5Y and 10Y periods is in the Trailing Returns section. Rolling returns show how consistently the fund beats its category over time.
What is the Sharpe ratio of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
The Sharpe ratio of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth is in the Alpha, Beta & Sharpe section of the Performance tab. Sharpe ratio = (fund return − risk-free rate) ÷ standard deviation, and measures return per unit of risk taken.
What is the alpha of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
The alpha of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth is shown in the Alpha, Beta & Sharpe section. Alpha = fund return − (risk-free rate + beta × market excess return). A positive alpha is the fund manager's value-add above the benchmark.
What is the beta of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
The beta of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth is in the Alpha, Beta & Sharpe section. Beta below 1.0 means lower volatility than the benchmark; above 1.0 means higher sensitivity to market moves.
What are the rolling returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
Rolling returns for WhiteOak Capital Pharma and Healthcare Fund Direct-Growth across all 1Y, 3Y, 5Y investment windows are shown in the Rolling Returns section. Unlike trailing returns, rolling returns reveal how the fund has performed across all possible entry and exit dates — offering a much more complete picture of consistency.
How consistent are the period-wise returns of WhiteOak Capital Pharma and Healthcare Fund Direct-Growth?
Period-wise annual returns for WhiteOak Capital Pharma and Healthcare Fund Direct-Growth across each financial year are in the Period Returns section. This shows whether the fund has been positive in most years and how it has fared in bear markets.